Related Experiment Video
Updated: Mar 13, 2026

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
Yuki Kawarada1, Yasumichi Inoue1,2, Fumihiro Kawasaki1
1Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, 467-8603 Nagoya, Japan.
Abstract:
Transforming growth factor β (TGF-β) signaling facilitates tumor development during the advanced stages of tumorigenesis, but induces cell-cycle arrest for tumor suppression during the early stages. However, the mechanism of functional switching of TGF-β is still unknown, and it is unclear whether inhibition of TGF-β signaling results amelioration or exacerbation of cancers. Here we show that the tumor suppressor p53 cooperates with Smad proteins, which are TGF-β signal transducers, to selectively activate plasminogen activator inhibitor type-1 (PAI-1) transcription. p53 forms a complex with Smad2/3 in the PAI-1 promoter to recruit histone acetyltransferase CREB-binding protein (CBP) and enhance histone H3 acetylation, resulting in transcriptional activation of the PAI-1 gene. Importantly, p53 is required for TGF-β-induced cytostasis and PAI-1 is involved in the cytostatic activity of TGF-β in several cell lines. Our results suggest that p53 enhances TGF-β-induced cytostatic effects by activating PAI-1 transcription, and the functional switching of TGF-β is partially caused by p53 mutation or p53 inactivation during cancer progression. It is expected that these findings will contribute to optimization of TGF-β-targeting therapies for cancer.
Insights
The tumor suppressor p53 enhances transforming growth factor β (TGF-β) signaling to activate plasminogen activator inhibitor type-1 (PAI-1) transcription, promoting tumor suppression. This interaction explains TGF-β functional switching in cancer progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Transforming growth factor β (TGF-β) signaling has dual roles in cancer, promoting tumor development in advanced stages but suppressing tumors early on.
- The mechanism behind TGF-β's functional switching and the impact of its inhibition on cancer remain unclear.
- Understanding the interplay between TGF-β and key cellular regulators is crucial for cancer therapy optimization.
Purpose of the Study:
- To elucidate the mechanism by which TGF-β signaling switches function during tumorigenesis.
- To investigate the role of the tumor suppressor p53 in TGF-β-mediated gene regulation.
- To determine the contribution of p53 and plasminogen activator inhibitor type-1 (PAI-1) to TGF-β's cytostatic effects.
Main Methods:
- Investigated the interaction between p53 and Smad proteins (TGF-β signal transducers) at the PAI-1 promoter.
- Assessed the recruitment of CREB-binding protein (CBP) and histone acetylation in response to TGF-β signaling.
- Evaluated the requirement of p53 for TGF-β-induced cytostasis and the role of PAI-1 in this process across multiple cell lines.
Main Results:
- p53 forms a complex with Smad2/3 at the PAI-1 promoter, recruiting CBP to enhance histone H3 acetylation and activate PAI-1 transcription.
- p53 is essential for TGF-β-induced cell-cycle arrest (cytostasis).
- PAI-1 plays a significant role in mediating the cytostatic effects of TGF-β.
Conclusions:
- p53 cooperates with TGF-β signaling to induce cytostasis via PAI-1 transcriptional activation.
- p53 mutation or inactivation contributes to the functional switching of TGF-β from tumor suppression to promotion during cancer progression.
- These findings provide insights for optimizing TGF-β-targeted cancer therapies.
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
Activation and Inactivation of G Proteins
Cell Specific Gene Expression
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
General Transcription Factors

